Literature DB >> 25883122

Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.

Michael M Graham1, Richard L Wahl2, John M Hoffman3, Jeffrey T Yap3, John J Sunderland4, Ronald Boellaard5, Eric S Perlman6, Paul E Kinahan7, Paul E Christian3, Otto S Hoekstra5, Gary S Dorfman8.   

Abstract

The Uniform Protocols for Imaging in Clinical Trials (UPICT) (18)F-FDG PET/CT protocol is intended to guide the performance of whole-body FDG PET/CT studies within the context of single- and multiple-center clinical trials of oncologic therapies by providing acceptable (minimum), target, and ideal standards for all phases of imaging. The aim is to minimize variability in intra- and intersubject, intra- and interplatform, interexamination, and interinstitutional primary or derived data. The goal of this condensed version of the much larger document is to make readers aware of the general content and subject area. The document has several main subjects: context of the imaging protocol within the clinical trial; site selection, qualification, and training; subject scheduling; subject preparation; imaging-related substance preparation and administration; imaging procedure; image postprocessing; image analysis; image interpretation; archiving and distribution of data; quality control; and imaging-associated risks and risk management.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  PET CT; fluorodeoxyglucose; guideline; protocol

Mesh:

Substances:

Year:  2015        PMID: 25883122      PMCID: PMC4587663          DOI: 10.2967/jnumed.115.158402

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

Review 1.  Fusion imaging: a new type of technologist for a new type of technology. July 31, 2002.

Authors: 
Journal:  J Nucl Med Technol       Date:  2002-12

Review 2.  Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.

Authors:  R Edward Coleman; Dominique Delbeke; Milton J Guiberteau; Peter S Conti; Henry D Royal; Jeffrey C Weinreb; Barry A Siegel; Michael F Federle; David W Townsend; Lincoln L Berland
Journal:  J Nucl Med       Date:  2005-07       Impact factor: 10.057

3.  Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Authors:  Lalitha K Shankar; John M Hoffman; Steve Bacharach; Michael M Graham; Joel Karp; Adriaan A Lammertsma; Steven Larson; David A Mankoff; Barry A Siegel; Annick Van den Abbeele; Jeffrey Yap; Daniel Sullivan
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

4.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

Review 5.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

6.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

Authors:  Ronald Boellaard; Mike J O'Doherty; Wolfgang A Weber; Felix M Mottaghy; Markus N Lonsdale; Sigrid G Stroobants; Wim J G Oyen; Joerg Kotzerke; Otto S Hoekstra; Jan Pruim; Paul K Marsden; Klaus Tatsch; Corneline J Hoekstra; Eric P Visser; Bertjan Arends; Fred J Verzijlbergen; Josee M Zijlstra; Emile F I Comans; Adriaan A Lammertsma; Anne M Paans; Antoon T Willemsen; Thomas Beyer; Andreas Bockisch; Cornelia Schaefer-Prokop; Dominique Delbeke; Richard P Baum; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

7.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Authors:  Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-02       Impact factor: 9.236

  7 in total
  56 in total

1.  The engagement of FDG PET/CT image quality and harmonized quantification: from competitive to complementary.

Authors:  Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01       Impact factor: 9.236

2.  Method for detecting voxelwise changes in fluorodeoxyglucose-positron emission tomography brain images via background adjustment in cancer clinical trials.

Authors:  Lei Qin; Armin Schwartzman; Keisha McCall; Nezamoddin N Kachouie; Jeffrey T Yap
Journal:  J Med Imaging (Bellingham)       Date:  2017-06-01

Review 3.  Using PET for therapy monitoring in oncological clinical trials: challenges ahead.

Authors:  C M Deroose; S Stroobants; Y Liu; L K Shankar; P Bourguet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-27       Impact factor: 9.236

4.  Longitudinal monitoring of reconstructed activity concentration on a clinical time-of-flight PET/CT scanner.

Authors:  Lawrence R MacDonald; Amy E Perkins; Chi-Hua Tung
Journal:  J Med Imaging (Bellingham)       Date:  2016-11-23

5.  Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.

Authors:  Benjamin Houdu; Charline Lasnon; Idlir Licaj; Guy Thomas; Pascal Do; Anne-Valerie Guizard; Cédric Desmonts; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-14       Impact factor: 9.236

6.  Patient's weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients.

Authors:  Charline Lasnon; Benjamin Houdu; Emmanuel Kammerer; Thibault Salomon; Jeremy Devreese; Adrien Lebasnier; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01       Impact factor: 9.236

Review 7.  Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0.

Authors:  Joo Hyun O; Martin A Lodge; Richard L Wahl
Journal:  Radiology       Date:  2016-02-24       Impact factor: 11.105

Review 8.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

9.  Measuring temporal stability of positron emission tomography standardized uptake value bias using long-lived sources in a multicenter network.

Authors:  Darrin Byrd; Rebecca Christopfel; Grae Arabasz; Ciprian Catana; Joel Karp; Martin A Lodge; Charles Laymon; Eduardo G Moros; Mikalai Budzevich; Sadek Nehmeh; Joshua Scheuermann; John Sunderland; Jun Zhang; Paul Kinahan
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-04

Review 10.  Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans.

Authors:  Kong Y Chen; Aaron M Cypess; Maren R Laughlin; Carol R Haft; Houchun Harry Hu; Miriam A Bredella; Sven Enerbäck; Paul E Kinahan; Wouter van Marken Lichtenbelt; Frank I Lin; John J Sunderland; Kirsi A Virtanen; Richard L Wahl
Journal:  Cell Metab       Date:  2016-08-09       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.